Free Trial

3 Underperforming Nasdaq 100 Stocks Worth a Closer Look

Key Points

  • The strategy of rotating to the Nasdaq’s biggest laggards is far from foolproof, but it makes good sense.
  • Despite being down more than 40% year-to-date, analysts still have faith in Enphase Energy.
  • Moderna’s mRNA pipeline includes 45 vaccine and therapeutic candidates.
  • The company also announced a partnership with IBM to explore the use of generative AI and quantum computing in mRNA science.
  • With a consensus price target that implies nearly 80% upside, Zscaler could be one of the Nasdaq-100’s biggest comeback stories of 2023-2024.
  • Interested in Enphase Energy? Here are five stocks we like better.

unlock icon  Upgrade Now

This premium article is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

Should You Invest $1,000 in Enphase Energy Right Now?

Before you consider Enphase Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enphase Energy wasn't on the list.

While Enphase Energy currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Enphase Energy (ENPH)
4.8109 of 5 stars
$44.59-6.5%N/A60.26Hold$70.54
Moderna (MRNA)
4.325 of 5 stars
$28.54+2.6%N/A-3.08Hold$58.70
Zscaler (ZS)
3.4853 of 5 stars
$226.17+1.0%N/A-904.68Moderate Buy$236.66
Verizon Communications (VZ)
4.6735 of 5 stars
$44.07+2.6%6.15%10.64Moderate Buy$47.41
Intel (INTC)
3.67 of 5 stars
$20.10-1.2%2.49%-4.59Reduce$22.23
PDD (PDD)
4.8534 of 5 stars
$105.57+1.4%N/A10.31Moderate Buy$169.91
T-Mobile US (TMUS)
4.6324 of 5 stars
$246.95+2.2%1.43%25.54Moderate Buy$257.68
Activision Blizzard (ATVI)
0.7068 of 5 stars
$94.42flat1.05%34.59N/AN/A
Meta Platforms (META)
4.4822 of 5 stars
$549.00-1.0%0.38%22.95Moderate Buy$681.95
Tesla (TSLA)
4.167 of 5 stars
$282.16-3.4%N/A138.31Hold$287.46
Align Technology (ALGN)
4.3322 of 5 stars
$173.30-2.5%N/A30.89Moderate Buy$245.75
Merck & Co., Inc. (MRK)
5 of 5 stars
$85.23+0.6%3.80%12.66Moderate Buy$111.13
International Business Machines (IBM)
4.2819 of 5 stars
$241.87+1.0%2.76%37.73Hold$242.41
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Related Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
5 Stocks to BUY Now as Tariff Uncertainty Fades
3 Stocks to Buy on the Dip—and 3 to Dump Fast

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines